Margi Shah
Psychiatry · Brooklyn, NYNPI 1184762056
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 341 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by AbbVie at 25.7% of the total. 2025 is the largest year on record at $1,600, 2.6 times the $608 reported in 2019. Among psychiatry clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 341 payments — averaging $17.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Otsuka America Pharmaceutical, Inc.$859
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$841
- Alkermes, Inc.$444
- Neurocrine Biosciences, Inc.$401
- Vanda Pharmaceuticals Inc.$381
- plus $2K from 16 others
What the payments were for
- Food & beverage$6,019100%
- Education$150%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 119 | $1,549 |
| Otsuka America Pharmaceutical, Inc. | 48 | $859 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 39 | $841 |
| Alkermes, Inc. | 20 | $444 |
| Neurocrine Biosciences, Inc. | 19 | $401 |
| Vanda Pharmaceuticals Inc. | 16 | $381 |
| Lundbeck LLC | 18 | $346 |
| Axsome Therapeutics, Inc. | 15 | $293 |
| Johnson & Johnson | 15 | $281 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $190 |
| E.r. Squibb & Sons, L.L.C. | 5 | $109 |
| Teva Pharmaceuticals USA, Inc. | 3 | $62 |
| Shire North American Group Inc | 4 | $56 |
| Almatica Pharma LLC | 2 | $45 |
| Tempus AI, Inc | 2 | $42 |
| Avanir Pharmaceuticals, Inc. | 2 | $32 |
| Jazz Pharmaceuticals Inc. | 1 | $23 |
| Sunovion Pharmaceuticals Inc. | 1 | $20 |
| Azurity Pharmaceuticals, Inc. | 1 | $18 |
| Neuronetics, Inc. | 1 | $15 |
| Eisai Inc. | 1 | $14 |
| Idorsia Pharmaceuticals US Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$111
How this compares
$6,034 in reported general payments places this provider in the 90th percentile of 3,713 psychiatry providers in New York.
Other psychiatry in Brooklyn
- Mark OwensBrooklyn$286K
- Nancy Abdel-WahabBrooklyn$253K
- Stephan CarlsonBrooklyn$184K
- Louis BelzieBrooklyn$161K
- Nikhil PalekarBrooklyn$115K
- Alexander PinkusovichBrooklyn$95K
- Leslie CitromePomona$5.7M
- Sanjay GuptaCheektowaga$1.9M
- Richard PriceMonsey$1.7M
- Adam AshtonAmherst$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.